Form 4 for MEDS DataMeds AI, Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-21 · accession 0001641172-25-000551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-21 | MEDS | Norton Brian | CEO | A - Grant | $0.00 | +9.00M | 9.04M | +20,125% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, Par Value $0.0001 | 2025-03-21 | A | A | 9,000,000 | $0.00 | 9,044,720 | D | — | — | (F1) Shares of restricted stock issued pursuant to the Wellgistics Health, Inc. Amended and Restated 2023 Equity Incentive Plan. The shares shall fully vest solely upon the achievement of certain financial metrics for the years ending December 31, 2025, 2026, and 2027. The first vesting opportunity is during the first quarter of 2026. |